Reduced Blood Cell Adhesion on Polypropylene Substrates through a Simple Surface Zwitterionization.
To overcome the thrombogenic reactions of hydrocarbon-based biomaterials in clinical blood treatment, we introduce a model study of surface zwitterionization of a polypropylene (PP) substrate using a set of well-defined copolymers for controlling the adhesion of blood cells in vitro. Random and block copolymers containing zwitterionic units of 2-methacryloyloxyethyl phosphorylcholine (MPC), [3-(methacryloylamino)propyl]dimethyl(3-sulfopropyl)ammonium hydroxide inner salt (SBAA), or nonionic units of 2-hydroxyethyl methacrylate (HEMA) with a controlled hydrophobic segment of 70% n-butyl methacrylate (BMA) units in these polymers were synthesized through reversible addition-fragmentation chain transfer polymerization. A systematic study of how zwitterionic and nonionic copolymer architectures associated with controlled chain orientation via hydration processes affect blood compatibility is reported. The surface wettability of PP substrates coated with the block copolymer with poly(MPC) (PMPC) segments was higher than that of the random copolymer poly(MPC-random-BMA). However, only the random copolymers with SBAA units demonstrate a higher surface wettability. The PP substrate coated with nonionic copolymers containing HEMA units showed relatively lower hydration capability associated with higher protein adsorption, platelet adhesion, and leukocyte attachment than those with zwitterionic copolymers. The random copolymer poly(SBAA-random-BMA) coated on the PP substrates exhibited resistance to cell adhesion in human whole blood at a level comparable to that of MPC copolymers. An ideal zwitterionic PP substrate could be obtained by coating it with a block copolymer composed of PMPC and poly(BMA) (PBMA) segments, PMPC-block-PBMA. The water contact angle decreased dramatically from approximately 100° on the original PP substrate to 11° within 30 s. The number of blood cells attached on PMPC-block-PBMA decreased significantly to less than 2.5% of that on original PP. These results prove that the rational design of zwitterionic polymers incorporated with a hydrophobic anchoring portion provides a promising approach to reduce blood cell adhesion and protein adsorption of hydrocarbon-based biomaterials applied in direct contact with human whole blood.
R&D Center for Membrane Technology and ‡Department of Chemical Engineering, Chung Yuan University , Chung-Li, Taoyuan 320, Taiwan.|Department of Materials Engineering and ∥Department of Bioengineering, School of Engineering, The University of Tokyo , 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
Sheng-Han
SH
Chen
R&D Center for Membrane Technology and ‡Department of Chemical Engineering, Chung Yuan University , Chung-Li, Taoyuan 320, Taiwan.|Department of Materials Engineering and ∥Department of Bioengineering, School of Engineering, The University of Tokyo , 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
Yung
Y
Chang
R&D Center for Membrane Technology and ‡Department of Chemical Engineering, Chung Yuan University , Chung-Li, Taoyuan 320, Taiwan.|Department of Materials Engineering and ∥Department of Bioengineering, School of Engineering, The University of Tokyo , 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
Kazuhiko
K
Ishihara
D001672:Biocompatible Materials / Q000737:chemistry; D002448:Cell Adhesion / Q000187:drug effects; D006801:Humans; D008422:Materials Testing; D008689:Methacrylates / Q000737:chemistry; D010767:Phosphorylcholine / Q000031:analogs & derivatives / Q000737:chemistry; D011108:Polymers / Q000737:chemistry; D011126:Polypropylenes / Q000737:chemistry* / Q000494:pharmacology
D001672:Biocompatible Materials; D008689:Methacrylates; D011108:Polymers; D011126:Polypropylenes; D010767:Phosphorylcholine; C070638:2-methacryloyloxyethyl phosphorylcholine; C005044:hydroxyethyl methacrylate; C016284:butyl methacrylate